$28.53
0.652.33%
最終更新: Nov 6, 4:00 PM
Benzinga
Benzinga
Benzinga
金曜日, 11 06
Benzinga
© 2026 Benzinga | All Rights Reserved
Parabilis Medicines (PBLS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-2.32 | $-0.23 | -908.7 % |
Quarterly Revenue (Billions)
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $148.00K | $16.67M | -99.1 % |
| Metric | Q2 '26 |
|---|---|
| Earnings Per Share (Non-GAAP) | |
| Estimate | $-0.23 |
| Actual | $-2.32 |
| Surprise | -908.7% |
| Revenue | |
| Estimate | $16.7M |
| Actual | $148000 |
| Surprise | -99.1% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.38 | $-0.39 | $-0.37 | $-0.38 |
| Revenue | ||||
| Consensus | $500000 | $1.0M | — | — |